PATENT CLAIM ANALYSIS

Application Number: 16247170
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-08
Patent Classification: ["514", "249000"]

Abstract:
The present invention relates to compounds of the formula (I), or pharmaceutically acceptable salts, enantiomer or diastereomer thereof, wherein R 1  to R 4  and Q are as described above. The compounds may be useful for the treatment or prophylaxis of hepatitis B virus infection.

Claim (Index 9):
A process for the preparation of a compound according to  claim 1  comprising any one of the following steps:\n a) the reaction of compound of formula (V), \n with an acid followed by reaction with phenyl carbamate (VI); b) the reaction of iodide (IX), with an acid followed by reaction with phenyl carbamate (VI); wherein R 2  and R 3  are defined as in  claim 1 ; R 5  and R 6  together with the nitrogen and sulfur atom they are attached to form a 4-10 membered heterocyclyl.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 99.0
- Lexical Diversity: 1.26829
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14997346', '16196324', '16247084', '11208962', '11413872']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.810468630647759
- 35 USC 102 Novelty (BERT): 0.5641828672817231
- Combined Prediction Score: 0.7858400543111553
- Mean Citation Score: 411.434974
- Max Citation Score: 512.69696
- Similarity Product: 328.9995183978653

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test